Skip to main content

and
  1. No Access

    Article

    Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database

    The aim of this study was to evaluate the risk of acute myocardial infarction in patients taking osteoporosis medication. Patients were taken from the SIDIAP or CPRD database and were matched using propensity ...

    S. Khalid, S. Calderon-Larranaga, A. Sami, S. Hawley in Osteoporosis International (2022)

  2. No Access

    Article

    Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD)

    We describe variation across geographical regions of England in operations undertaken following presentation of hip fracture and in 30-day mortality. Some significant geographic variation in 30-day mortality w...

    A. Shah, S. Hawley, D. S. Inman, C. Cooper, E. Fagan in Osteoporosis International (2021)

  3. Article

    Open Access

    Lifetime revision risk for medial unicompartmental knee replacement is lower than expected

    Unicompartmental knee replacement (UKR) is widely considered to be a pre-total knee replacement (TKR) particularly in the young. The implication of this is that it is sensible to do a UKR, even though it will ...

    J. A. Kennedy, E. Burn, H. R. Mohammad in Knee Surgery, Sports Traumatology, Arthros… (2020)

  4. No Access

    Article

    Social inequality and fractures—secular trends in the Danish population: a case-control study

    We examined links between markers of social inequality and fracture risk in the Danish population, demonstrating that high income and being married are associated with a significantly lower risk.

    L. Hansen, A. Judge, M.K. Javaid, C. Cooper, P. Vestergaard in Osteoporosis International (2018)

  5. No Access

    Article

    Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK

    The venous thromboembolism risk among anti-osteoporotics is unknown. In this primary care study, the risk with other bisphosphonates [1.05 (0.94–1.18) and 0.96 (0.78–1.18)], strontium [0.90 (0.61–1.34) and 1.1...

    E. Martín-Merino, I. Petersen, S. Hawley in Osteoporosis International (2018)

  6. No Access

    Article

    Costs of fragility hip fractures globally: a systematic review and meta-regression analysis

    Purpose This study was conducted in order to systematically review the costs of hip fractures globally and identify drivers of differences in costs. Methods A systematic review was con...

    S. Williamson, F. Landeiro, T. McConnell, L. Fulford-Smith in Osteoporosis International (2017)

  7. No Access

    Article

    Geographic variation in secondary fracture prevention after a hip fracture during 1999–2013: a UK study

    Fragility fractures of the hip have a major impact on the lives of patients and their families. This study highlights significant geographical variation in secondary fracture prevention with even the highest p...

    A. Shah, D. Prieto-Alhambra, S. Hawley, A. Delmestri in Osteoporosis International (2017)

  8. Article

    Open Access

    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery

    There is variation in how services to prevent secondary fractures after hip fracture are delivered and no consensus on best models of care. This study identifies healthcare professionals’ views on effective ca...

    S. Drew, A. Judge, C. Cooper, M. K. Javaid, A. Farmer in Osteoporosis International (2016)

  9. Article

    Open Access

    Impact of hip fracture on hospital care costs: a population-based study

    Using a large cohort of hip fracture patients, we estimated hospital costs to be £14,163 and £2139 in the first and second year following fracture, respectively. Second hip and non-hip fractures were major cos...

    J. Leal, A. M. Gray, D. Prieto-Alhambra, N. K. Arden in Osteoporosis International (2016)

  10. No Access

    Article

    Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England

    There is variation in how services to prevent second fractures after hip fracture are organised. We explored this in more detail at 11 hospitals. Results showed that there was unwarranted variation across a nu...

    S. Drew, S. Sheard, J. Chana, C. Cooper, M. K. Javaid in Osteoporosis International (2014)

  11. No Access

    Article

    Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial

    Patients with cognitive impairment (CI) often do not receive secondary fracture prevention. Use of zoledronic acid led to a similar reduction in re-fracture risk but the survival benefit was limited to those w...

    D. Prieto-Alhambra, A. Judge, N. K. Arden, C. Cooper in Osteoporosis International (2014)

  12. No Access

    Article

    Burden of pelvis fracture: a population-based study of incidence, hospitalisation and mortality

    The objective of this study was to describe the incidence and consequences of pelvic fractures in a community cohort. The incidence of pelvic fractures increases with age with a protective effect of higher bod...

    D. Prieto-Alhambra, F. F. Avilés, A. Judge, T. Van Staa in Osteoporosis International (2012)

  13. No Access

    Article

    Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis

    We have shown that patients with osteoarthritis are at increased risk of fracture after total knee replacement (TKR). We conducted a population-based cohort study to assess the effect of bisphosphonate use on ...

    D. Prieto-Alhambra, M. K. Javaid, A. Judge, J. Maskell in Osteoporosis International (2011)